Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Revenue (2019 - 2025)

Historic Revenue for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $21.8 million.

  • Biodesix's Revenue rose 1992.73% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.2 million, marking a year-over-year increase of 2228.58%. This contributed to the annual value of $71.3 million for FY2024, which is 4529.92% up from last year.
  • Biodesix's Revenue amounted to $21.8 million in Q3 2025, which was up 1992.73% from $20.0 million recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Revenue peaked at $28.9 million during Q1 2021, and registered a low of $6.5 million during Q3 2021.
  • Its 5-year average for Revenue is $14.4 million, with a median of $13.5 million in 2023.
  • In the last 5 years, Biodesix's Revenue surged by 46644.43% in 2021 and then crashed by 7731.59% in 2022.
  • Quarter analysis of 5 years shows Biodesix's Revenue stood at $7.2 million in 2021, then surged by 32.99% to $9.6 million in 2022, then surged by 52.68% to $14.7 million in 2023, then surged by 39.28% to $20.4 million in 2024, then grew by 6.55% to $21.8 million in 2025.
  • Its last three reported values are $21.8 million in Q3 2025, $20.0 million for Q2 2025, and $18.0 million during Q1 2025.